A clinical case of hypertrophic cardiomyopathy and family hyperlipidemia

Abstract

Introduction of the next generation sequencing to the clinical practice made it possible to accurately diagnose a number of cardiac diseases, and to study accumulation of pathological variants of genes in families thus identifying individuals at risk of the disease much earlier. The authors present a patient with two genetically determined cardiological diseases — familial hyperlipidemia and hypertrophic cardiomyopathy.

Keywords

familial hyperlipemia / hypertrophic cardiomyopathy / sequencing

References

[1] Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS Guidelines for the management of dyslipidaemias. Rev Esp Cardiol (Engl Ed). 2017;70(2):115. doi: 10.1016/j.rec.2017.01.002.

[2] Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the european atherosclerosis society. Eur Heart J. 2013;34(45):3478–3490a. doi: 10.1093/eurheartj/eht273.

[3] Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97(11):3956–3964. doi: 10.1210/jc.2012-1563.

[4] de Ferranti SD, Rodday AM, Mendelson MM, et al. Prevalence of familial hypercholesterolemia in the 1999 to 2012 united states national health and nutrition examination surveys (NHANES). Circulation. 2016;133(11):1067–1072. doi: 10.1161/CIRCULATIONAHA.115.018791.

[5] Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the heart rhythm society (HRS) and the european heart rhythm association (EHRA). Heart Rhythm. 2011;8(8):1308–1339. doi: 10.1016/j.hrthm.2011.05.020.

[6] Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2010;31(22):2715–1726. doi: 10.1093/eurheartj/ehq271.

RIGHTS & PERMISSIONS

Dankovtseva E.N., Zateyshchikov D.A.